1. Home
  2. OGN vs WSBC Comparison

OGN vs WSBC Comparison

Compare OGN & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • WSBC
  • Stock Information
  • Founded
  • OGN 1923
  • WSBC 1870
  • Country
  • OGN United States
  • WSBC United States
  • Employees
  • OGN N/A
  • WSBC N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • WSBC Major Banks
  • Sector
  • OGN Health Care
  • WSBC Finance
  • Exchange
  • OGN Nasdaq
  • WSBC Nasdaq
  • Market Cap
  • OGN 2.5B
  • WSBC 2.8B
  • IPO Year
  • OGN N/A
  • WSBC N/A
  • Fundamental
  • Price
  • OGN $9.33
  • WSBC $32.87
  • Analyst Decision
  • OGN Hold
  • WSBC Buy
  • Analyst Count
  • OGN 4
  • WSBC 6
  • Target Price
  • OGN $18.00
  • WSBC $38.50
  • AVG Volume (30 Days)
  • OGN 4.7M
  • WSBC 456.5K
  • Earning Date
  • OGN 08-05-2025
  • WSBC 10-22-2025
  • Dividend Yield
  • OGN 0.85%
  • WSBC 4.49%
  • EPS Growth
  • OGN N/A
  • WSBC N/A
  • EPS
  • OGN 2.69
  • WSBC 1.65
  • Revenue
  • OGN $6,281,000,000.00
  • WSBC $690,805,000.00
  • Revenue This Year
  • OGN N/A
  • WSBC $42.49
  • Revenue Next Year
  • OGN $1.36
  • WSBC $16.47
  • P/E Ratio
  • OGN $3.50
  • WSBC $20.02
  • Revenue Growth
  • OGN N/A
  • WSBC 22.64
  • 52 Week Low
  • OGN $8.01
  • WSBC $26.42
  • 52 Week High
  • OGN $22.67
  • WSBC $37.36
  • Technical
  • Relative Strength Index (RSI)
  • OGN 43.86
  • WSBC 62.71
  • Support Level
  • OGN $8.95
  • WSBC $32.27
  • Resistance Level
  • OGN $9.25
  • WSBC $33.09
  • Average True Range (ATR)
  • OGN 0.28
  • WSBC 0.63
  • MACD
  • OGN 0.00
  • WSBC 0.27
  • Stochastic Oscillator
  • OGN 22.54
  • WSBC 93.39

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About WSBC WesBanco Inc.

Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.

Share on Social Networks: